Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
Villa, D., Connors, J.M., Shenkier, T.N., Gascoyne, R.D., Sehn, L.H., Savage, K.J.
Published in Annals of oncology (01.05.2010)
Published in Annals of oncology (01.05.2010)
Get full text
Journal Article
A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency
Ramadan, K.M., Shenkier, T., Sehn, L.H., Gascoyne, R.D., Connors, J.M.
Published in Annals of oncology (01.01.2007)
Published in Annals of oncology (01.01.2007)
Get full text
Journal Article
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Gerrie, A.S., Power, M.M., Shepherd, J.D., Savage, K.J., Sehn, L.H., Connors, J.M.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J.F., Kelly, K., Gribben, J., Pfreunschuh, M., Morschhauser, F., Schoder, H., Zelenetz, A.D., Rademaker, J., Advani, R., Valente, N., Fortpied, C., Witzig, T.E., Sehn, L.H., Engert, A., Fisher, R.I., Zinzani, P.-L., Federico, M., Hutchings, M., Bollard, C., Trneny, M., Elsayed, Y.A., Tobinai, K., Abramson, J.S., Fowler, N., Goy, A., Smith, M., Ansell, S., Kuruvilla, J., Dreyling, M., Thieblemont, C., Little, R.F., Aurer, I., Van Oers, M.H.J., Takeshita, K., Gopal, A., Rule, S., de Vos, S., Kloos, I., Kaminski, M.S., Meignan, M., Schwartz, L.H., Leonard, J.P., Schuster, S.J., Seshan, V.E.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma
Owen, C, Berinstein, N L, Christofides, A, Sehn, L H
Published in Current oncology (Toronto) (01.04.2019)
Published in Current oncology (Toronto) (01.04.2019)
Get full text
Journal Article
Observation as the initial management strategy in patients with mantle cell lymphoma
Abrisqueta, P., Scott, D.W., Slack, G.W., Steidl, C., Mottok, A., Gascoyne, R.D., Connors, J.M., Sehn, L.H., Savage, K.J., Gerrie, A.S., Villa, D.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic
Sehn, L H, Kuruvilla, P, Christofides, A, Stakiw, J
Published in Current oncology (Toronto) (01.06.2020)
Published in Current oncology (Toronto) (01.06.2020)
Get full text
Journal Article
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
Hitz, Felicitas, Connors, J. M., Gascoyne, R. D., Hoskins, P., Moccia, A., Savage, K. J., Sehn, L. H., Shenkier, T., Villa, D., Klasa, R.
Published in Annals of hematology (01.11.2015)
Published in Annals of hematology (01.11.2015)
Get full text
Journal Article
Tafasitamab plus lenalidomide versus standard of care as second‐line (2L) therapy for patients with R/R DLBCL: A post hoc internal 2L analysis of L‐MIND (IN 2L‐MIND)
Sehn, L. H., Kuruvilla, J., Salles, G., Maddocks, K. J., Koch, C., Xue, Z., Amoloja, T., Amin, A., Duell, J.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study
Alzahrani, M., El-Galaly, T.C., Hutchings, M., Hansen, J.W., Loft, A., Johnsen, H.E., Iyer, V., Wilson, D., Sehn, L.H., Savage, K.J., Connors, J.M., Gascoyne, R.D., Johansen, P., Clasen-Linde, E., Brown, P., Villa, D.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
Analysis of Real‐World Treatment Patterns and Outcomes Among Patients With Relapsed/Refractory Follicular Lymphoma Including POD24 Patients
Sehn, L. H., Wang, A., Yu, J., Kamalakar, R., Sail, K., Sinai, W., Arnette, D., Yang, S., Mutebi, A., Navarro, F. R., Salles, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma
Skrabek, P, Assouline, S, Christofides, A, MacDonald, D, Prica, A, Sangha, R, Matthews, B A, Sehn, L H
Published in Current oncology (Toronto) (01.08.2019)
Published in Current oncology (Toronto) (01.08.2019)
Get full text
Journal Article
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia
Banerji, V, Aw, A, Robinson, S, Doucette, S, Christofides, A, Sehn, L H
Published in Current oncology (Toronto) (01.12.2020)
Published in Current oncology (Toronto) (01.12.2020)
Get full text
Journal Article
Impact of the Dark Zone Signature on Central Nervous System Relapse in a Real‐World Diffuse Large B‐cell Lymphoma Population
Alduaij, W., Jiang, A., Collinge, B., Ben‐Neriah, S., Hilton, L. K., Boyle, M., Meissner, B., Farinha, P., Slack, G., Villa, D., Gerrie, A. S., Mungall, A. J., Steidl, C., Sehn, L. H., Scott, D. W., Savage, K.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study
Hu, B., Reagan, P. M., Sehn, L. H., Sharman, J., Hertzberg, M., Zhang, H., Kim, A., Herbaux, C., Molina, L., Maruyama, D., Smolewski, P., Stenner, F., Craine, V., Kothari, R., Hirata, J., Sahin, D., Sugidono, M., Lee, C., Tilly, H.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY
Herrera, A. F., Tracy, S., Sehn, L. H., Jardin, F., Lenz, G., Trněný, M., Salles, G., Flowers, C. R., Tilly, H., Sharman, J. P., Friedberg, J. W., Balasubramanian, S., Raghavan, V., Hirata, J., Lee, C., Jiang, Y., Morschhauser, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2
Sehn, L. H, Chamuleau, M., Lenz, G., Clausen, M. R., Haioun, C., Izutsu, K., Davies, A., Zhu, J., Oki, T., Szafer‐Glusman, E., Conlon, R., Chiou, H., Ipe, D., Elliot, B., Wu, J., Salles, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
ESCALADE: A PHASE 3 STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP FOR PATIENTS ≤65Y WITH UNTREATED NON‐GERMINAL CENTER B‐CELL–LIKE DIFFUSE LARGE B‐CELL LYMPHOMA
Sehn, L. H., Kahl, B., Matasar, M., Lentz, G., Izutsu, K., Zhao, W., Tao, L., Calvo, R., Zinzani, P. L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY
Sehn, L. H., Bartlett, N. L., Matasar, M., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Shadman, M., Cheah, C. Y., Fay, K., Ku, M., Nastoupil, L., Wei, M. C., Yin, S., To, I., Hu, N., Min, J., Penuel, E., Belousov, A., Coimbra, A., Jemaa, S., Bender, B., Turner, D., Budde, L. E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article